Denali Therapeutics, Inc. (DNLI)
19.82
-1.02
(-4.89%)
USD |
NASDAQ |
Feb 10, 16:00
20.04
+0.22
(+1.11%)
Pre-Market: 09:18
Denali Therapeutics Market Cap : 3.095B for Feb. 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Protalix Biotherapeutics, Inc. | 217.14M |
| Enovis Corp. | 1.291B |
| Masimo Corp. | 7.203B |
| Twist Bioscience Corp. | 3.008B |
| Agenus, Inc. | 104.41M |
Market Cap Related Metrics
| PEG Ratio | -1.285 |
| Price to Book Value | 3.342 |
| Price | 19.82 |
| Earnings Yield | -14.69% |
| PEGY Ratio | -1.285 |